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ttp://dx.doi.org/10.1016/j.ajpath.2014.09.018The expression of ankyrin repeat domain protein 1 (Ankrd1), a transcriptional cofactor and sarcomeric
component, is strongly elevated by wounding and tissue injury. We developed a conditional Ankrd1ﬂ/ﬂ
mouse, performed global deletion with Sox2-cre, and assessed the role of this protein in cutaneous
wound healing. Although global deletion of Ankrd1 did not affect mouse viability or development,
Ankrd1/ mice had at least two signiﬁcant wound-healing phenotypes: extensive necrosis of ischemic
skin ﬂaps, which was reversed by adenoviral expression of ANKRD1, and delayed excisional wound
closure, which was characterized by decreased contraction and reduced granulation tissue thickness.
Skin ﬁbroblasts isolated from Ankrd1/ mice did not spread or migrate on collagen- or ﬁbronectin-
coated surfaces as efﬁciently as ﬁbroblasts isolated from Ankrd1ﬂ/ﬂ mice. More important, Ankrd1/
ﬁbroblasts failed to contract three-dimensional ﬂoating collagen gels. Reconstitution of ANKRD1 by
adenoviral infection stimulated both collagen gel contraction and actin ﬁber organization. These
in vitro data were consistent with in vivo wound closure studies, and suggest that ANKRD1 is important
for the proper interaction of ﬁbroblasts with a compliant collagenous matrix both in vitro and in vivo.
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Current address of N.W., Lab Corporation, Nashville, TN.As part of a gene expression proﬁling program to identify
genes altered after dermal wounding inmice, we reported that
ankyrin repeat domain protein 1 (Ankrd1; alias cardiac
ankyrin repeat protein) mRNA and protein levels were highly
induced and remained elevated during the healing process.1
Cells of the epidermis and dermis that showed induced
expression included vascular endothelial cells, cells of the
hair follicle bulb, the panniculus carnosus, keratinocytes,
monocytes, and ﬁbroblasts, indicating increased ANKRD1
may be a generalized stress response in many cell types of the
skin. Overexpression of ANKRD1, a member of the muscle
ankyrin repeat protein (MARP) family, which includes
Ankrd2 and Ankrd23,2 also improved many aspects of wound
healing in several animal models.1
The dynamics of MARP gene expression during both
normal muscle development and function and those seen
under pathological stress conditions in muscle and many other
tissues3e5 suggested that disruptions in normal MARP func-
tion could have dire consequences to the organism. However,stigative Pathology.
.a recent report observed that deletions of the MARP family
members, both individually and in combination, produced a
subtle phenotype.6 On the basis of the altered skeletal muscle
response to eccentric contraction, the authors suggested that
theMARPs are not essential for development or basal function
of skeletal muscle, but that they play a role in mechanical
behavior and stability of muscle after exercise. It was also
concluded that the three MARP proteins are structurally and
Ankrd1-Null Wound-Healing Phenotypesfunctionally redundant, because it required deletion of all three
genes to see a signiﬁcant effect. A recent study with the same
strains further concluded that theMARPs were not involved in
the response to cardiac pressure overload.7
We developed a conditional Ankrd1ﬂ/ﬂ mouse with the
ultimate goal of determining the role of ANKRD1 in various
cell types. As an initial approach, we generated a global
deletion for the purpose of studying ANKRD1 function in
all cell types involved in wound healing. We now report that
deletion of Ankrd1 results in a viable mouse with signiﬁcant
wound-healing phenotypes that are not compensated by
intact Ankrd2 or Ankrd23. Results of cell culture studies
suggest that part of this phenotype results from dysfunc-
tional cell-matrix interaction in ﬁbroblasts.
Materials and Methods
Recombination of Ankrd1 Conditional KO Mice
We designed a targeting vector to delete the mouse Ankrd1
gene basal promoter and protein-coding exons 1 and 2 (1.87
kb) when targeted mice were crossed with cre-recombinasee
expressing mice (Figure 1A). The targeting vector was con-
structed using 15 kb of Ankrd1 sequence that was retrieved
from strain 129S7/SvEvBrd-Hptrb-m2 mouse bacterial arti-
ﬁcial chromosome (BAC) library (bMQ-382E2; BACPAC
Resource Center, Children’s Hospital Oakland Research
Institute, Oakland, CA).8 Two cre-recombinase recognition
sequences (loxP) were introduced into the 15-kb BAC
sequence: the ﬁrst loxP was located approximately 7 kb
upstream of the 50 end, and the second loxP was inserted into
intron 2 approximately 6 kb upstream from the 30 end
(Figure 1A). A neomycin gene cassette ﬂanked by ﬂp-
recombinase recognition (frt) sites was inserted 50 of the
second loxP site. Herpes simplex virusethymidine kinase
was also included as a negative selection marker. Internal
EcoRV and SmaI sites were introduced into this 15-kb BAC
DNA for conﬁrmation of the targeted allele (Figure 1B).
Embryonic stem cells (129S6) were electroporated with the
linearized targeting vector in the Vanderbilt Transgenic/Em-
bryonic StemCell Core (Nashville, TN), and isolated colonies
were screened by Southern blot analysis. Positive clones were
injected into C57Bl/6J blastocysts. Resulting male pups that
were 70% chimeric were tested for germ-line transmission
by breeding to C57Bl/6J females. The neomycin cassette was
removed by breeding hemizygous (Ankrd1wt/ﬂ) mice to actin
promoter-driven, eﬂp-recombinase C57Bl/6J mice.
Hemizygous (Ankrd1wt/ﬂ) mice with the neomycin cassette
deleted were bred to homozygosity [Ankrd1ﬂ/ﬂ; ﬂanked by
loxP (FLOX)], followed by breeding to Sox2 promoter-driven
cre-recombinase C57Bl/6J mice. Because the Sox2 promoter
is expressed in the oocyte,9 all offspring acquired a recom-
bined allele, even when the Sox2 cre-recombinase transgene
did not segregate to the pup. Mice with deletion of one Ankrd1
allele [Ankrd1wt/; wild type (WT/)] were crossbred to
produce homozygous [Ankrd1/; knockout (KO)] mice.The American Journal of Pathology - ajp.amjpathol.orgMice lacking the Sox2-cre recombinase and eﬂp-recombinase
transgenes were selectively used for breeding to eliminate the
transgenes from the KO background. Initial phenotyping
studies used mixed-breed C57Bl/6J/129S6 FLOX,WT/, and
KO mice. Mice were further backcrossed to C57Bl/6J to
generate a pure inbred strain. The mice used for the excisional
wound studies had been backcrossed for eight generations.
Organ Weight Determination
Adult FLOX, WT/, and KO mice were weighed and eutha-
nized. The spleen, three lobes of the liver, one kidney, brain,
cardiac ventricles, and the gastrocnemius muscle (skeletal
muscle) were dissected and weighed. Organ/body weight ra-
tios were calculated. Differences among the three genotypes
were tested for signiﬁcance using Graphpad Prism version
5.03 (GraphPad Software, Inc., La Jolla, CA) and two-way
analysis of variance, with signiﬁcance set at P < 0.05.
Histopathological Evaluation of KO and FLOX Mice
Samples of tissue from all major organ systems of young
(5 to 6 months old) and aged (>1 year) adult male and fe-
male Ankrd1-null mice and FLOX age-matched controls were
collected, ﬁxed overnight in formalin, processed routinely,
divided into sections (5 mm thick), and stained with hematox-
ylin and eosin. The specimens underwent thorough gross and
microscopic evaluation of all organ systems by a veterinary
pathologist in the Division of Comparative Pathology,
Department of Pathology, Microbiology, and Immunology,
Vanderbilt University School ofMedicine (Nashville, TN). No
abnormalities were found.
Surgical Wounding Models
Studies were performed in the Association for Assessment and
Accreditation of Laboratory Animal Care Internationale
approved facilities of Vanderbilt University, under approval of
the Institutional Animal Care and Use Committee at Vanderbilt
University School of Medicine. FLOX (control) and KO male
mice (aged 15 to 20 weeks; nZ 8, each genotype) in a mixed
background and in eighth-generation C57Bl/6J background
received two 6-mm, full-thickness excisional wounds on the
dorsum. Wounds were photographed with a Canon PC1234
camera (Canon USA, Lake Success, NY). Wound areas were
determined using ImageJ software version 1.48 (NIH,Bethesda,
MD) and expressed as percentage of initial wound size. At
completion of the experiment, mice were euthanized, and the
complete wounds, including 2 mm of the wound margin, were
harvested and prepared for histological analysis.
Large excisional wounds were used to follow wound
closure rates in 15 C57BL/6 and 10 KO age-matched female
mice weighing 19 to 22 g. Under isoﬂurane anesthesia, the
dorsal surface was shaved with electric clippers, cleaned suc-
cessively with betadine and 70% isopropanol (3), and then
incised with a scalpel to produce a 15 15-mm, full-thickness97
Figure 1 Strategy for conditional deletion of
murine Ankrd1. A: Graphic representation of Ankrd1
gene structure shows the 600-bp proximal promoter
with known transcription factor binding sites and
the structural gene. All nine exons of the structural
gene encode for some portion of the protein.
Protein-encoding regions in all nine exons are
shown in gray, with the domain organization shown
below. Scissors indicate the region removed by cre-
recombinase. Adapted from Samaras et al5 and
modiﬁed with permission from Nature Publishing
Group. B: Cre-recombinase recognition sequences
(loxP; ﬂox) were inserted 600 bp upstream of the
transcription start site and in intron 2 of the Ankrd1
gene, which was included in a 15-kb restriction
fragment from a 129S6 mouse-derived BAC clone. A
neomycin resistance cassette, ﬂanked by eﬂp-
recombinase recognition sequences (frt), was
inserted into intron 2 just 50 of the downstream ﬂox
site. The neomycin resistance cassette was removed
by breeding targeted mice with mice expressing
actin promoter-driven eﬂp-recombinase. Subse-
quent breeding to mice expressing Sox2 promoter-
driven cre-recombinase produced global deletion
of the segment that contained the Ankrd1 proximal
promoter through exon 2.
Samaras et alwound. Each site was covered with a Tegaderm (3M, St. Paul,
MN) dressing to prevent dehydration and infection, and each
mouse was ﬁtted with a fabric sleeve (1.6-cm Surgitube;
Western Medical Ltd, Tenaﬂy, NJ) to prevent the wound site
from being disturbed. Animals were maintained in cages with
a 37C warming pad covering 50% of the cage bottom during
a recovery period of 4 to 6 hours, after which time cages were
returned to the animal facility. Each subject received 1 mL i.p.
of warm 0.9% sodium chloride for 3 days to avoid dehydra-
tion. The dressing was removed at day 7. Wound dimensions
were measured with an electronic digital caliper (15-cm;
Harbor Freight Tools, Camarillo, CA) on alternate days,
beginning at day 7 until healing was complete.
An ischemic skin ﬂap was generated on the dorsum by
making 1.5  2.0-cm skin ﬂaps with a rostral pedicle and
underlying the full ﬂap with a 0.13-mm thick silicone sheet
(Invotec International, Jacksonville, FL) that extended s.c.
0.25 cm beyond the ﬂap boundaries.10 The silicone sheet
was sutured to the internal fascia, and the ﬂap margins were
sutured to close the incisions. This paradigm effectively
prevented subdermal blood vessel inﬁltration into the ﬂap
from anywhere other than the pedicle, generating a graded,
proximodistal ischemia. Mice were euthanized at indicated
time points, and the ﬂaps were removed, cut either trans-
versely or longitudinally, and prepared for histological
analysis.98Transduction of adAnkrd1-GFP into Ischemic Skin Flaps
Fibrin clots containing virus were generated by mixing 10 mg/
mL ﬁbrinogen (Sigma-Aldrich, St. Louis, MO), 100 U/mL
thrombin (Sigma-Aldrich), and adenovirus expressing either
luciferase plus green ﬂuorescent protein (GFP; adLuc-GFP;
control) or ANKRD1 plus GFP (adAnkrd1-GFP)1 so that the
ﬁnal concentrations in the vehicle were 5 mg/mL ﬁbrinogen, 20
U/mL thrombin, and 2  1010 plaque-forming units of
adenovirus per ﬂap. Control ﬂaps were treated with an equiv-
alent dose of adLuc-GFP in ﬁbrin vehicle. Sterile saline was
added to adjust the volume of the solutions as needed. Virus
(300 mL in ﬁbrin vehicle) was injected between the skin and the
silicone sheet of each closed ﬂap.
Histological Analysis
Mice were euthanized by CO2 asphyxiation at the times
indicated later. The wounds plus surrounding skin were
excised and ﬁxed in neutral-buffered formalin overnight at
4C, embedded in parafﬁn, divided into sections, stained
with hematoxylin and eosin or Masson’s trichrome green
stain, and imaged (Olympus BX50 microscope, DP71
camera, and Software CellSens Standard 1.6; Olympus
Corporation, Center Valley, PA). Digital images of each
excisional wound were used to determine the distanceajp.amjpathol.org - The American Journal of Pathology
Figure 2 Partial or complete deletion of Ankrd1 mRNA and protein. Two
6-mm skin biopsy specimens were taken from the dorsum of FLOX, wild-type
(WT)/, and knockout (KO) mice for RNA and protein analysis. A: Ankrd1
mRNA is reduced to 42% of the FLOX levels in hemizygous mice and is
essentially undetectable in KO mice. B: Western blot analysis of ANKRD1
protein is difﬁcult to detect in uninjured (0 hours) skin of all three geno-
types1 but is sharply induced at 18 hours after wounding in both WT/ and
FLOX mice. Induction in hemizygous mice is approximately 50% that of the
FLOX mice, whereas no ANKRD1 is detected in KO mice. Cyclophilin A was
used as a loading control. h, hours.
Figure 3 Delayed excisional wound closure in Ankrd1/ mice. A: Gross
images of wounds at days 0, 4, 6, and 8 after biopsy show larger wound areas
for knockout (KO) mice compared to FLOX mice. B: The relative open wound
area decreases more rapidly in FLOX mice than KO mice. C: Hematoxylin and
eosin staining in representative FLOX and KO wounds shows wider and
thinner granulation tissue (dotted lines) in KO wounds. D: Granulation tissue
thickness is signiﬁcantly reduced in KO wounds compared to wounds in FLOX
mice. E: A larger wound gap between the cut edges of the panniculus car-
nosus (muscle gap) is measured in KO compared to FLOX wounds. n Z 12
(D and E). *P  0.05, ***P < 0.001, one-way analysis of variance (B);
*P  0.05, **P < 0.01, Student’s t-test (D and E).
Ankrd1-Null Wound-Healing Phenotypesbetween the edges of the panniculus carnosus as a measure
of original wound gap using ImageJ software. Digital im-
ages of the wounds were also used to measure the granu-
lation tissue thickness and cross-sectional area and the
extent of ischemic ﬂap necrosis with a 4 objective.
Cells
Mouse dermal ﬁbroblasts were isolated from FLOX and KO
neonatal skin, as previously described.11 Early-passage pop-
ulations of the isolated skin ﬁbroblasts were immortalized with
a simian virus (SV)40 large T-antigen plasmid.12 Brieﬂy, 100-
mm dishes of primary cells at 80% to 90% conﬂuence were
transfected with 8 mg of plasmid using Lipofectamine (Life
Technologies, Grand Island, NY) overnight at 37C in 5%
CO2, after which the transfection reagent was removed and
growth medium was added.12 Both primary and immortalized
cells were grown in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) containing 10% fetal bovine serum (FBS), 100 U/
mL penicillin-streptomycin (P/S), 1% antibiotic-antimycotic
(AA), and 2 mmol/L L-glutamine.
Migration Assay
Of a 12-well tissue culture plate, 4 wells were coated with
extracellular matrix (ECM) molecules by incubation in aThe American Journal of Pathology - ajp.amjpathol.orgtissue culture hood at room temperature. In each plate, two
wells were coated with collagen (rat tail type I; 100 mg/mL;
BD Biosciences, Bedford, MA) and two wells were coated
with ﬁbronectin (10 mg/mL; Santa Cruz Biotechnology,
Santa Cruz, CA), both in phosphate-buffered saline (PBS).
ECM solutions were removed after 2 hours, and the wells
were washed with sterile PBS and incubated with serum-free
DMEM at 37C in 5% CO2. FLOX and KO ﬁbroblasts at
80% conﬂuence were trypsinized from ﬂasks and counted
and diluted to a concentration of 6  105 cells/mL, a con-
centration that permitted cells to reach conﬂuence 24 hours
after plating. ECM-coated cell culture plates were secured
onto a magnetic array that aligned magnets in the center of
each of four coated wells. The media were removed from the
four coated wells, 500 mL of fresh growth medium was
added, and sterile, magnetically adherent stencils13 (MAtS)
(Supplemental Figure S1) were placed in the center of each
well. Cell suspensions (500 mL each) were equally distrib-
uted around the MAtS, one cell type per ECM, and the plates
were incubated for 24 hours to allow cells to attach and reach
conﬂuence. Plates were removed from the magnetic array,99
Figure 4 Protracted delay of large wound closure in the Ankrd1/
mouse. A: The 2.25-cm2 wounds close much more slowly than small exci-
sions, yielding a protracted healing response in the knockout (KO) mouse
compared to a cohort of equivalent age and size C57Bl/6J controls.
B: Wound dimensions consistently decrease in the KO strain. Statistically
signiﬁcant differences (multiple t-tests) were present up to 21 days.
*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
Figure 5 Necrosis of ischemic skin ﬂaps correlates with Ankrd1 zygosity.
Diagram depicts the sectioning pattern of the ischemic dorsal skin ﬂap. After
euthanasia at 12 days, the ﬂaps were excised, cut horizontally into four 4-mm
strips (dashed lines) to represent the tissue response as a function of distance
from the (cranial) base of the ﬂap, and embedded with the caudal edge of each
segment at the parafﬁn block face. Histological sections, 4 objective: The base
of ﬂaps, irrespective of genotype, shows an intact epidermis, a pale green
dermis penetrated by numerous hair follicles, s.c. fat, and a deep red panniculus
carnosus. At 50% of ﬂap length, hemizygous ﬂaps show a hypertrophic
epidermis, immature follicular structures, and a granular dermal response,
suggesting incomplete repair. Knockout (KO) ﬂaps show a transition from
intact, condensed dermal collagen to frank necrosis (bright red with trichrome
staining). By 75% of the ﬂap length, FLOX tissues also undergo signs of dete-
rioration, whereas hemizygous and KO tissues are highly necrotic. Frank necrosis
is present at the tip of the ﬂaps, although tissue disintegration is more prom-
inent in the KO animals. Necrosis at the distal end of the ischemic dorsal skin
ﬂaps of FLOX mice is minimal, <10% of ﬂap length. WT/ mice showed
approximately 25% to 50%necrosis, whereas 50% to 75%of the ﬂap on KOmice
became necrotic. Similar results were obtained in three separate experiments.
Samaras et aland the medium was carefully aspirated, to remove ﬂoating
cells, and replaced with fresh growth medium. The MAtS
were carefully removed to leave a cell-free, undisturbed,
four-arm, ECM-coated area in the center of each well. The
cell-free wells were ﬁlled with warm PBS to help prevent
drying of open plates, and the plate was placed in a humid-
iﬁed stage incubator (Bioscience Tools, San Diego, CA)
infused with 5% CO2, attached to a Zeiss Axiovert 200M
microscope (Carl Zeiss Microscopy LLC, Thornwood, NY)
with an automated stage driven by the Ludl Mac 2000 driver
module (Ludl Electronic Products Ltd., Hawthorne, NY).
Images were acquired every 10 minutes for 5 hours with a
Tucsen 3.3 MP cooled charge-coupled device digital mi-
croscope camera (OnFocus Laboratories, Lilburn, GA) using
a 10 objective. ImagePro Plus 3D with StagePro software
version 6.0 (Media Cybernetics Inc., Bethesda, MD) for100time-lapse image acquisition was used to acquire and process
images. Data analysis to determine percentage of total pixels
that were not covered (percentage open area) was done using
TScratch software version 1.0 for Windows without Matlab
Compiler Runtime (Swiss Federal Institute of Technology in
Zürich, Zürich, Switzerland).14Collagen Gel Contraction
Three-dimensional collagen lattices were prepared as previ-
ously described.15 Brieﬂy, type I rat tail collagen (BD
Biosciences, San Jose, CA) was diluted with 20mmol/L acetic
acid to 3 mg/mL. Primary or immortalized skin ﬁbroblasts
isolated from neonatal FLOX and KO mice were cultured in
DMEM (10% FBS, 1% AA, and 1% P/S), trypsinized, and
counted. Collagen (200 mL) neutralized to pH 7.0 with 1N
sodium hydroxidewas loaded into eachwell of a 24-well plate.
Cells (1.5 105) were suspended in 400 mL of DMEM (10%
FBS, 1% AA, and 1% P/S) and added to the wells containing
200 mL of collagen solution to yield a ﬁnal concentration of 1
mg/mL. The gels were then incubated at 5%CO2 and 37C for
30 minutes to allow the collagen to polymerize. After collagen
polymerization, 500 mL of DMEM (10% FBS, 1% AA, and
1% P/S) was added to each well. By using a sterile spatula,
each gel was mechanically released from the wall and bottom
of the wells. Collagen lattices were imaged (GelLogic200ajp.amjpathol.org - The American Journal of Pathology
Ankrd1-Null Wound-Healing PhenotypesImaging System, Molecular Imaging System version 7.1;
Carestream Health, Inc., Woodbridge, CT) every 24 hours, and
lattice area was analyzed using the Molecular Imaging software
(Carestream Health, Inc.). Reduction in lattice area due to
contraction was determined at daily intervals up to 7 days.
Adenovirus Infection/Reconstitution
FLOX and KO immortalized skin ﬁbroblasts were infected
with either adAnkrd1-GFP or adLuc-GFP as a control, at a
multiplicity of infection of 100. Cells were harvested 48
hours after infection, and used for collagen gel contraction
assays or protein isolation.
Protein Extraction
Whole cell extracts were prepared in radioimmunoprecipitation
assay lysis buffer (Sigma-Aldrich, St. Louis, MO) containing a
protease inhibitor cocktail (Complete Mini Protease Inhibitor
Tablets; Roche, Mannheim, Germany), followed by soni-
cation at 4C using a Branson 250 Soniﬁer (Emerson In-
dustrial Automation, Danbury, CT) with a water bath cup
horn attachment. Protein concentration in cleared lysates
was determined by BCA protein assay kit (Thermo-
Scientiﬁc, Rockford, IL), and lysates were stored at80C.
Western Blot Analysis
Aliquots containing 30 mg protein from cell extracts were
separated by 10% polyacrylamide SDS-PAGE and transferred
to a polyvinylidene diﬂuoride membrane (Immobilon;
Millipore, Billerica, MA) using the NuPage (Life Technolo-
gies, Carlsbad, CA) blotting apparatus, following the manu-
facturer’s protocol. After blocking with a solution of 10
mmol/L Tris-HCl, pH 8, 150 mmol/L NaCl, 0.05% Tween 20,
and 5% milk powder, the membrane was incubated with anti-
ANKRD1 antibody (1:2000) and anti-cyclophilin (1:20,000;
BML-SA296; Enzo, Farmingdale, NY) at 4C overnight,
followed by incubation with anti-rabbit IgG (C2609; Santa
Cruz Biotechnology) at room temperature for 30 minutes. The
membrane was washed and incubated with Western Lightning
Plus Enhanced Chemiluminescent Reagent (Perkin Elmer,
Waltham, MA), and protein bands were visualized and
quantiﬁed using a Kodak Image Station 4000 MM Pro with
Kodak MI software version 5.3.3.17476 (Standard Editon;
Carestream Health, Inc.). For the virus reconstitution studies,
protein was isolated from cells 48 hours after infection.
RNA Preparation and Analysis
RNA was isolated using the Illustra RNAspin Mini Isolation
Kit (GE Healthcare, Piscataway, NJ), according to manu-
facturer’s instructions. RNA concentration was determined
spectrophotometrically (Nanodrop; Thermo Scientiﬁc,
Wilmington, DE), and samples were stored at 80C.The American Journal of Pathology - ajp.amjpathol.orgTaqMan real-time quantitative PCR forAnkrd1,Ankrd2, and
Ankrd23 (see probe and primer sequences below) and cyclo-
philin (Applied Biosystems, Foster City, CA), as the house-
keeping control, was performed on 50 ng reverse-transcribed
RNA with the following primers and probes: Ankrd1, 50-AG-
ACTCCTTCAGCCAACATGATG-30 (forward), 50-CTCTC-
CATCTCTGAAATCCTCAGG-30 (reverse), and 50-CCCCT-
GCCTCCCCATTGCCATTCT-30 (probe); Ankrd2, 50-GCA-
GTGGAGGGGAAAATGAAAG-30 (forward), 50-CTGTCC-
GACGGAACTCATCAC-30 (reverse), and 50-TCCGCTGAA-
CCTCCQTCCGCCA-30 (probe); and Ankrd23, 50-ACTGCC-
TAGAGCACCTTATCG-30 (forward), 50-GGAAGCCACA-
TTCTTCACACC-30 (reverse), and 50-GCCCACATCAACG-
CACAGGATAAG-30 (probe).
Phalloidin Staining
Collagen lattices were ﬁxed in 4% paraformaldehyde in phos-
phate buffer after 3 days of culture. Gels were stained following
the manufacturer’s instructions. Brieﬂy, ﬁxed collagen gels
were treated with 0.1% Triton X-100 (Sigma-Aldrich) in PBS
for 5 minutes and washed twice with PBS. To reduce nonspe-
ciﬁc staining, 1% bovine serum albumin in PBS was added to
the gels for 30 minutes before staining with rhodamine phal-
loidin (Invitrogen, Carlsbad, CA) and SYTOX green nucleic
acid staining (Invitrogen). SYTOX green nucleic acid stain (1
mmol/L) and 12.5 mL of rhodamine phalloidin were diluted in
500 mL PBS per well and incubated with the gels for 30minutes
at room temperature. Gels were washed twice with PBS, fol-
lowed by confocal analysis under 20 magniﬁcation using the
Perkin Elmer Opera QEHS Automated Confocal Microscopy
System (PerkinElmer,Waltham,MA) at the Vanderbilt Institute
for Integrative Biosystems Research and Education Core Fa-
cility. Confocal images were analyzed using Columbus Soft-
ware version 3.2 (PerkinElmer).
Results
In Vivo Analysis of Ankrd1 Deletion
To analyze the effects of Ankrd1 deletion on wound healing,
we placed loxP sites 600 bp upstream of the Ankrd1 proximal
promoter and in intron 2, thereby excising the transcription
start site and exon 1 and 2 coding sequences (Figure 1A). This
design ensured that Ankrd1 could, in future studies, be selec-
tively deleted in any tissue that expressed cre-recombinase. To
achieve global deletion of the protein, Sox2 promoter-driven,
cre-recombinaseeexpressing, C57Bl/6J mice were bred to
FLOX mice. Mixed background FLOX, WT/, and KO adult
mice were evaluated. All litters had a normal numbers of pups,
and genotyping conﬁrmed that each genotype was born at the
expected allelic distribution with no obvious effects on
development, growth, or reproduction as a result of either the
insertion of the loxP sites or the deletion of Ankrd1, suggesting
that Ankrd1 is expendable under normal physiological condi-
tions in mixed background mice. However, backcrossing for101
Figure 6 Adenoviral ANKRD1 overexpression rescues the necrotic pheno-
type in ischemic Ankrd1/ wounds. A: Ischemic ﬂaps in knockout (KO) mice
were underlain with ﬁbrin clots containing either adenoviral adLuc-GFP or
adAnkrd1-GFP before ﬂap suturing. Mice were euthanized at 10 days. Flaps that
received adLuc-GFP have a high percentage of necrosis by day 10, as illustrated
in the gross image and in the trichrome green-stained, longitudinal sections.
Abnormal dermal architecture and lack of hair follicles are also evident. Flaps
treated with an adAnkrd1-GFP vector develop little to no necrosis, dermal
alteration, or follicular destruction. B: Quantitative analysis of the extent of
necrosis in both FLOX and KO mice shows the far greater necrotic response in
the KO mouse and the capacity of overexpression of ANKRD1-GFP by adenoviral
administration (adAnkrd1-GFP) to reverse the effects of ischemia.
Samaras et aleight generations into the pure inbred C57Bl/6J strain resulted
in a growth-diminishing effect of Ankrd1 deletion that was
observed in the neonate and carried through to the adult
(Supplemental Figure S2).
We conﬁrmed the Ankrd1 deletion by mRNA analysis in
skin. Because Ankrd1 expression is low in normal skin, but
sharply and strongly induced after wounding, we generated
full-thickness, dorsal excisional wounds in FLOX, WT/, and
KO adult mice. Tissue was harvested 18 hours after injury for
mRNA and protein analysis. WT/ wound tissue had >50%
reduction of Ankrd1 mRNA, and transcripts were essentially
undetectable in KO tissue (Figure 2A). Similarly, theANKRD1
protein content of FLOX wound tissue was strongly ampliﬁed
over that in intact (0 hours) skin, signiﬁcantly diminished inWT/
 wound tissue, and undetectable in wounds of KO mice
(Figure 2B). Wound contraction in all three genotypes was
similar at 18 hours, although there was a mild impairment in
wound contraction in mice with deletion of either one or both
Ankrd1 alleles (Supplemental Figure S3). These data conﬁrmed
the complete deletion of Ankrd1mRNA and protein expression
in skin of KOmice and showed that there was no compensatory
overexpression from the WT allele in the WT/ mouse.
Because we saw no dramatic effects of Ankrd1 deletion
on development or viability, effects on organ development
were studied. Organ weights, expressed as a percentage of
body weight, of the spleen, liver, kidney, brain, and skeletal
muscle from FLOX, WT/, and KO adult male and female
mice showed no differences (Supplemental Figure S4).
However, the weight of the cardiac ventricles relative to
body weight was moderately increased in female mice with
a single Ankrd1 allele, and relative ventricular weight in
both sexes increased signiﬁcantly with the deletion of both
alleles (Supplemental Figure S4).
To evaluate histopathological changes thatmight occur with
aging after Ankrd1 deletion, young (5 to 6 months old) and
aged (>1 year) adult male and female, FLOX and KO mice
were examined in the Vanderbilt Comparative Pathology
Core. Gross visual examination by a veterinary pathologist
found no abnormalities in any tissues. Microscopic examina-
tion of hematoxylin and eosinestained sections from all major
organ systems also revealed no abnormalities.
Ankrd2 and Ankrd23 Expression Does Not Compensate for
the Loss of Ankrd1
The three members of the MARP family are functionally
redundant, at least in skeletal muscle.6 To investigate
possible compensation for Ankrd1 deletion by one or both of
the other MARPs, skin, heart, and skeletal muscle samples
were collected from FLOX and KOmice for quantiﬁcation of
Ankrd2 and Ankrd23 mRNA. There was no difference in
Ankrd23 mRNA levels in any of the three tissues. Ankrd2
mRNA, the primary MARP in skeletal muscle, decreased in
both skeletal muscle tissue and skin from KO mice
(Supplemental Figure S5). This response was consistent with
evidence for an involvement of ANKRD1 in MyoD-depen-
dent transcription of Ankrd2.16 In summary, these data102showed that neither Ankrd2 nor Ankrd23 compensated, at the
transcriptional level, for the loss of Ankrd1.
Deletion of Ankrd1 Produces a Wound Contraction
Phenotype
The biological role of ANKRD1 was only partially impli-
cated by the effects of its overexpression1 and our recent
demonstration of the effects of gene deletion on Mmp13 and
Mmp10 in the KO mouse.16 On the basis of preliminary
observations in 18-hour wounds (Supplemental Figure S3),
we analyzed wound contraction in FLOX and KO mice toajp.amjpathol.org - The American Journal of Pathology
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Figure 7 Deletion of Ankrd1 retards ﬁbroblast migration on collagen and
ﬁbronectin substrates. Migration of FLOX (ﬂ/ﬂ) and knockout (KO; /)
ﬁbroblasts was studied on ﬁbronectin or collagen-coated surfaces using the
magnetically adherent stencils (MAtS) technique to form a gap in the
monolayer. A: Comparative migration on a collagen substrate. KO ﬁbroblasts
(squares: solid line) migrate signiﬁcantly slower on collagen than FLOX cells
(circles: dotted line), with differences seen as early as 1.5 hours. B:
Comparative migration on a ﬁbronectin substrate. KO ﬁbroblast migration on
ﬁbronectin is signiﬁcantly slower than FLOX ﬁbroblasts at 1.0 hours and more
so from 2 to 5 hours. C: Relative migration of KO cells on two substrates. KO
ﬁbroblasts migrate more rapidly on ﬁbronectin than on collagen. D: Relative
migration of FLOX ﬁbroblasts. These cells migrate at similar rates on ﬁbro-
nectin and collagen, although signiﬁcant differences are seen at later time
points (two-way analysis of variance with Bonferroni multiple-comparisons
test). *P < 0.05 (B); ***P < 0.001 (A and B); *P < 0.05 (1.5 to 2.5
hours), **P < 0.01 (both 3.0 and 4.0 hours), and ***P < 0.001 (4.5 to 5.0
hours) (C); *P < 0.05 (3.0 hours), ***P < 0.001 (4.0 to 5.0 hours) (D).
Ankrd1-Null Wound-Healing Phenotypesthe point of near closure. Bilateral, full-thickness, unsplinted
excisional wounds (6 mm thick) were made on the dorsum
and imaged daily for 8 days (Figure 3A). The wounds of the
KO mice contracted more slowly than those of the FLOX
mice. Measurements of the wounds showed a particularly
signiﬁcant delay in contraction between 6 and 8 days
(Figure 3B). Histomorphometric analysis of KO wound
sections revealed both signiﬁcantly thinner granulation tis-
sue (Figure 3, C and D) and an increased gap between the
wound edges, as demarcated by the intact panniculus car-
nosus of wounds (Figure 3, C and E). However, overall
granulation tissue cross-sectional area was similar between
the genotypes (Supplemental Figure S6). The change in the
shape, rather than the implied volume of granulation tissue,
suggested that the delay in closure of KO wounds resulted
from decreased contraction and not overall granulation tis-
sue formation. By using this contraction model, epithelial-
ization was unimpeded in the KO group.
Because small excisional wounds contract rapidly, we
repeated the analysis with WT C57Bl/6J and eighth-
generation C57Bl/6J-backcrossed KO mice of matching
age and weight in a second model, a large excisional wound
(Figure 4A). The large wound dimensions override the ability
of loose murine skin to extend rapidly over the wound, and
granulation tissue evolves over several weeks into a dense
scar with aligned collagen ﬁbers (data not shown). In this
model, KO wound contraction and closure were signiﬁcantly
retarded relative to FLOX mice until at least 21 days after
injury (Figure 4B). Wound size remained higher in the KO
mice throughout the experiment.
Reduction or Loss of Ankrd1 Results in Increased Necrosis of
Ischemic Skin Flaps
We previously showed that virally mediated overexpression
of ANKRD1 in wound models resulted in markedly
increased blood vessel development.1 To study the effect of
Ankrd1 depletion in an ischemic wound model, we generated
dorsal skin ﬂaps in the three Ankrd1 genotypes, with a rostral
pedicle that was underlain with a silicone sheet. By 12 days,
distinct, progressively more severe degrees of necrosis were
evident in the ﬂaps of FLOX, WT/, and KO mice, respec-
tively (Figure 5). In representative transverse sections,
trichrome staining showed overt necrosis at only the distal
portion of the FLOX ﬂap, with increased collagen density,
reduced cellularity, and fewer hair follicles in the distal 25%.
The WT/ ﬂap showed an intermediate response, with
increased necrosis through at least 25% of the ﬂap, reduction
of hair follicles, increased collagen condensation, and dermal
thickening at 50% of the ﬂap length. This effect was far more
exaggerated in the KO ﬂap, with overt necrosis, loss of
epidermal appendages, and severe alteration of dermal ar-
chitecture evident in 50% of the ﬂap. Analysis of several ﬂaps
conﬁrmed the progressive extent of ischemic damage with
deletion of one or both Ankrd1 alleles.
To show that the absence of ANKRD1 was central to the
necrotic phenotype in the ischemic ﬂap, ANKRD1 wasThe American Journal of Pathology - ajp.amjpathol.orgvirally reconstituted in the ﬂaps of KO and FLOX mice.
Adenoviral particles that transduced either luciferase plus
GFP or ANKRD1 plus GFP were embedded in ﬁbrin clots
and placed between the silicone sheet and the skin ﬂap to
release viral particles into the overlying ﬂap tissue. Viral
expression was conﬁrmed by bioluminescent and ﬂuores-
cence imaging of mice that were transduced with the adLuc-
GFP construct (Supplemental Figure S7). The ﬂaps of KO
mice transduced with adLuc-GFP showed the same necrotic
phenotype as untransduced KOmice (Figure 6A). In contrast,
the mice transduced with adAnkrd1-GFP showed signiﬁ-
cantly reduced necrosis. Quantiﬁcation of the effects of both
gene deletion and viral treatment in both genotypes is shown
in Figure 6B. In ﬂaps of the FLOX mouse treated with the
control virus, tissue necrosis was 20%, whereas KO mice
showed a threefold increase in tissue damage. In the presence
of adenoviral-delivered ANKRD1, FLOX ﬂaps showed little
to no necrosis, whereas the necrotic response in the KO
animals was reduced by a factor of 6.
In Vitro Analysis of Ankrd1 Deletion
Dermal Fibroblasts from KO Mice Have an Altered Phenotype
Because granulation tissue morphological characteristics
were differentially affected by Ankrd1 deletion, dermal ﬁ-
broblasts were isolated from KO and FLOX mice and103
Figure 8 Ankrd1/ ﬁbroblasts fail to contract
collagen gels. A: Cell number dependency. Cells
(6  104, 9  104, or 1.2  105 per well) were
plated in 1 mg/mL collagen lattices in a 24-well
tissue culture plate and were detached after
polymerization (left panel). After 24 hours, de-
tached lattices (dashed circles) containing FLOX
ﬁbroblasts demonstrate increasing collagen
contraction in a cell numberedependent manner,
whereas no contraction occurs in collagen lattices
containing knockout (KO) ﬁbroblasts, regardless of
cell number. Quantiﬁcation of the collagen lattice
area. Cell densityedependent collagen lattice
contraction at day 1 is signiﬁcantly different
between FLOX (white bars) and KO (black bars)
ﬁbroblasts (right panel). B: Time dependency.
Collagen lattices (1 mg/mL) containing 1.5  105
cells per well were formed in 24-well culture plates
and detached at 24 hours. Collagen lattices con-
taining FLOX ﬁbroblasts contract over time,
whereas KO ﬁbroblast lattices maintain a defective
ability to contract up to day 7 (left panel).
Quantiﬁcation of collagen gel area over a 7-day
interval. FLOX ﬁbroblasts produce rapid, time-
dependent contraction, whereas little contraction
is observed in KO ﬁbroblasts up to 7 days (right
panel). ****P < 0.0001, Student’s t-test.
Samaras et alimmortalized with the SV40 large T antigen. Experiments
were performed with cells between passages 2 and 10,
because all of the cells exhibited morphological changes at a
higher passage (Supplemental Figure S8).
Adhesion to and migration on ECM were analyzed using a
MAtS assay with both collagen I and ﬁbronectin substrates (as
described inMaterials andMethods).We observed that KO cells
took longer than FLOX cells to attach to the collagen matrix, but
both ﬁbroblast genotypes were stably attached before stencil
removal,which initiated cellmigration.BothKOandFLOXcells
closed the open area more completely on ﬁbronectin-coated
(open area, FLOX versus KO Z 54%  1.75% versus
72% 0.24%) than on collagen-coated (open area, FLOXversus
KOZ 62% 3.36% versus 80% 2.71%) substrate (Figure 7,
A and B). Both cell types migrated to a signiﬁcantly lesser extent
on collagen than ﬁbronectin (P< 0.001 at 5 hours) (Figure 7, C
and D), and KO ﬁbroblast migration was signiﬁcantly slower
than FLOX migration on either substrate. In summary, KO ﬁ-
broblasts had an impaired ability to interact with and to migrate
on two common matrix substrates.
KO Fibroblasts Fail to Contract Collagen Lattices
Wound contraction plays a signiﬁcant role in closure of
dermal wounds in loose-skinned rodents, and wound104contraction in vivo was markedly affected by the deletion of
Ankrd1. We used both primary and immortalized KO and
FLOX mouse ﬁbroblasts to compare their ability to contract
ﬁbroblast-populated collagen lattices (FPCLs). One day
after FPCL release from the wall of the tissue culture plate
well, there was signiﬁcant (P < 0.0001) contraction, even
with the fewest FLOX ﬁbroblasts, but little or no FPCL
contraction by KO cells, irrespective of the cell number
(Figure 8A). KO ﬁbroblast-populated FPCL failed to
signiﬁcantly contract FPCL, even when incubated for up to
a week (Figure 8B) or with increasing serum concentration
(Supplemental Figure S9). Similar results were found when
using nonimmortalized cells.
Reconstitution of ANKRD1 by viral transduction was used
to show that the absence of ANKRD1 was central to the
contraction failure phenotype of the KO cells. Western blot
analysis showed that transduction with adLuc-GFP had no
effect on cellular ANKRD1 levels in KO cells (Figure 9A).
Transduction with adAnkrd1-GFP increased ANKRD1 in
FLOX cells and reconstituted expression in KO cells
(Figure 9A). Ampliﬁcation of ANKRD1 in FLOX ﬁbroblasts
improved their ability to contract the FPCL ﬁbroblasts and
increased the rate of contraction in KO cells by a factor of
approximately 3 (Figure 9B). Rhodamine-phalloidin stainingajp.amjpathol.org - The American Journal of Pathology
Figure 9 Reconstitution of ANKRD1 in Ankrd1/ ﬁbroblasts restores
their ability to contract collagen lattices. A: Western blot analysis of FLOX
ﬁbroblasts infected with adLucegreen ﬂuorescent protein (GFP; Luc) and
adAnkrd1-GFP (Ankrd1) show overexpression of ANKRD1 after infection with
adAnkrd1-GFP. ANKRD1 protein is absent in extracts from knockout (KO)
ﬁbroblasts infected with adLuc-GFP but is easily detectable after infection
with adAnkrd1-GFP. Cyclophilin A was used as a loading control. B: Gel
contraction (dashed circles) accelerates by overexpression of ANKRD1 in
FLOX ﬁbroblasts at days 1 and 3; reconstitution of ANKRD1 in KO ﬁbroblasts
is signiﬁcantly restored. KO ﬁbroblast contraction at all time points.
**P < 0.01 (FLOX group), ***P < 0.001 (KO group), multiple t-tests.
Figure 10 Actin-rich network assembly after reconstitution of ANKRD1
in Ankrd1-deﬁcient ﬁbroblasts. Collagen lattices were loaded with equal
numbers of FLOX or knockout (KO) ﬁbroblasts and infected with either
adenoviral luciferaseegreen ﬂuorescent protein (GFP; adLuc-GFP) or
ANKRD1-GFP (adAnkrd1-GFP) expression vectors. Cells were stained with
phalloidin-red (actin) and SYTOX green (nuclei). Fibrillar actin networks are
prominent in collagen gels populated with FLOX ﬁbroblasts infected with
Ankrd1-Null Wound-Healing Phenotypesof F-actin in FPCL after infection of FLOX ﬁbroblasts with
adLuc-GFP revealed an abundant ﬁlamentous actin network,
whereas there was poor actin assembly or formation of
cellular extensions in similarly transduced KO ﬁbroblasts
(Figure 10). Adenoviral reconstitution of ANKRD1 in KO
ﬁbroblasts under conditions that also promoted gel contrac-
tion increased the staining of an F-actin network. These data
are consistent with our in vivo wound closure studies and
suggest that ANKRD1 is necessary for proper interaction of
ﬁbroblasts with a collagenous matrix, at least under low
tension, in vivo and in vitro.adLuc-GFP (ad-Luc) and are more abundant after ANKRD1 overexpression
with adAnkrd1-GFP (ad-Ankrd1). Actin ﬁbers are nearly absent in KO cells
treated with adLuc-GFP and markedly increase by ANKRD1 overexpression.
Insets: The degree of ﬁbroblast-populated collagen lattice contraction, as
illustrated in Figure 9. Collaged lattices populated by KO ﬁbroblasts had a
much lower cell density because of absent (adLuc-GFP) or reduced
(adAnkrd1-GFP) contraction.Discussion
Elevated Ankrd1 expression marks numerous developmental
and pathological events, including cardiomyogenesis andThe American Journal of Pathology - ajp.amjpathol.orgneovascularization during tissue repair, and overexpression
of Ankrd1 can enhance healing in several animal wound
models.17,18 Despite the resultant implication that ANKRD1
could be critical to development, we found that global dele-
tion of murine Ankrd1 yielded ventricular mass increases
(in a mixed genetic background), whereas an effect on
growth emerged in the pure, inbred C57Bl/6J background. In
contrast to the modest developmental effects, the physio-
logical stress of two types of wounding clearly discriminated
the Ankrd1 phenotype. Ischemic injury produced a dramatic
defect in skin ﬂap survival that was proportional to gene
dosage and was corrected by adenoviral gene delivery. This
vascular effect was consistent with our earlier observations
on ANKRD1 overexpression in several wound models.1
Ankrd1 deletion also retarded excisional wound closure and
granulation tissue contraction; furthermore, both the matrix-
dependent migration and contractility of KO skin ﬁbroblasts
were markedly impaired compared to normal cells. Previous
reports of deletion of one or all of the MARPs have detected
minor effects.6,7,19 The present ﬁndings in ischemic ﬂaps and
excisional wounds are highly consistent with the concept that
ANKRD1 abundance becomes a rate-limiting factor when
cells and tissues are challenged by injury and stress.
Because of the widespread expression of Ankrd1 during
development and injury, we began an exploration of the role
of ANKRD1 by a global deletion of the gene from a FLOX
mouse strain using a Sox2 promoter-driven cre-recombinase
that is activated in the oocyte. Although gene deletion was
readily conﬁrmed in both the hemizygous and homozygous
states, the offspring showed no striking pathological conditions105
Samaras et aland a normal litter size. With continued inbreeding of the
original 129 line to a pure C57Bl/6J background, the null
offspring showed a mild growth effect. In light of the modest
phenotype, we considered the possible compensatory effects of
the other two MARP proteins; however, at the level of gene
expression, there was no evidence of MARP up-regulation in
response to Ankrd1 deletion. Indeed, there appeared to be a
reduced level of Ankrd2 expression that could be related to the
inhibition of MyoD-dependent Ankrd2 expression after
knockdown of Ankrd1 by siRNA treatment of skeletal mus-
cle.16 Deletion of all three MARPs provides evidence of skel-
etal muscle weakness,6 but the mouse strains in that study
showed no developmental abnormalities, as in this report, or, in
a more recent report, response to cardiac pressure overload.7
However, we have recently identiﬁed Ankrd1-dependent
abnormalities in mice after both myocardial infarction and a-
adrenergic stimulation (L. Zhong,M. Chiusa, A. Cadar, A. Lin,
S.E. Samaras, J.M. Davidson, C.C. Lim, unpublished data).
Cellular Actions of Ankrd1
The interpretation of the Ankrd1-null phenotype is complicated
by the multiple roles of ANKRD1. In the sarcomere,
ANKRD1 is a titin-associated structural component that,
together with myopalladin, calpain protease p94, and calse-
questrin, forms a complex that appears to be critical for
sarcomere stability of differentiating cardiomyocytes
in vitro.3,4,20,21 Reduction of Ankrd1 mRNA and protein in rat
cardiomyocytes by siRNA or doxorubicin leads to sarcomere
disintegration and myoﬁbrillar disarray,20 presumably due to a
combination of loss of ANKRD1 from the I-band complex and
reduced expression of a range of ANKRD1 transcriptional
targets. It has also been suggested that members of the MARP
family serve a role in the muscle cell as part of a mechano-
sensory apparatus, in which MARPs act as shuttles to transport
factors, such as Tp53, to the nucleus.3,21,22 The MARP pro-
teins may also shuttle between cytoplasm and nucleus as part
of a stress-related regulatory pathway. We have recently
observed that ANKRD1 is involved in the transport of GATA-
4 from the sarcomere to the nucleus of the cardiomyocyte
(L. Zhong, M. Chiusa, A. Cadar, A. Lin, S.E. Samaras, J.M.
Davidson, C.C. Lim, unpublished data).
On the basis of many foregoing studies, depletion of
ANKRD1 could be expected to affect both cytoplasmic and
nuclear processes. Several studies have suggested that a key
role of sarcomeric MARPs is mechanotransduction that is
initiated by transportation of the protein from the cytoplasm
to the myocyte nucleus.3 Desmin is another cytoplasmic
partner whose depletion leads to up-regulation of Ankrd1.23
The MARPs are associated with several aspects of tran-
scriptional control in striated muscle, including associations
with YB-1,18 Tp53,16,21 and nucleolin.16 Early develop-
mental studies showed that the high-level expression of
Ankrd1 was associated with down-regulation of myocyte
proteins by association with YB-1. We have recently sug-
gested, on the basis of knockout, knockdown, and106overexpression studies in skin ﬁbroblasts, that the association
of ANKRD1 with nucleolin leads to the down-regulation of
AP-1estimulated Mmp13 and Mmp10 expression.16
The MARP Proteins and Stress
Physiological and pathological stresses affect both
expression levels and cellular distribution of the MARPs in
striated muscle.3 Stretch and contraction of striated muscle
induce MARP expression as well as increase protein
localization in both the I-band and the nucleus. However,
some differences have been reported for the individual
MARPs between fetal and adult, skeletal and cardiac
muscle. Elevated Ankrd1 expression in humans is widely
associated with both hypertrophic and dilated car-
diomyopathies,22,24e26 and ANKRD1 protein and mRNA
levels frequently increase in patients with end-stage heart
failure.27,28 Mutations in Ankrd1 that impair association
with the putative mechanosensing complex in the sarco-
mere have been found in patients with heritable
hypertrophic and dilated cardiomyopathies.4 These muta-
tions were also observed to cause altered muscle-speciﬁc
gene expression. Although there is less known about
ANKRD2 function in the heart, its ability to interact with
similar transcriptional regulators as ANKRD1 and to alter
muscle-speciﬁc protein expression suggests that its dysre-
gulation is also important in cardiac disease.16
Alterations in MARP expression in nonmuscle tissue under
stress have also been widely observed. Increased ANKRD1
expression in renal podocytes was associated with severity of
proteinuria in patients with lupus nephritis29 and with cisplatin
resistance in ovarian cancer chemotherapy.30 Gene expression
proﬁling after crush injury of peripheral and central dorsal root
ganglion neurons suggested that the expression of ANKRD1
might contribute to nerve regeneration.31
Impaired Wound and Collagen Contraction in the
Absence of Ankrd1
Conﬁrming initial observations, we documented reduced
contraction and healing in unsplinted excisional wounds of
KO mice up to 8 days. Granulation tissue thickness was also
signiﬁcantly reduced in these excisional wounds, although
the apparent volume of granulation tissue was similar in
both FLOX and somewhat growth-retarded KO mice. A
larger, more restrained wound model that compared
contraction in weight-matched KO and WT C57Bl/6J mice
showed highly signiﬁcant retardation of wound contraction
up to at least 3 weeks.
Although the present report evaluates the effects of global
Ankrd1 deletion, the defect in contraction of the wound
margins and granulation tissue was certainly consistent with
the inefﬁciency of KO skin ﬁbroblast migration on matrix-
coated substrates and the inability of these null cells to
contract a FPCL, a model that is often considered an in vitro
analogue of (compliant) granulation tissue. Inhibition ofajp.amjpathol.org - The American Journal of Pathology
Ankrd1-Null Wound-Healing Phenotypescontraction was also observed with aortic vascular smooth
muscle cells (unpublished data).
Collagen degradation can inﬂuence FPCL contraction.32
We recently reported that KO ﬁbroblasts strongly up-
regulate both Mmp10 and Mmp13 expression in vitro and
Mmp13 expression in vivo.16Matrixmetalloproteinase (MMP)
overexpression was even more strongly induced in both
anchored and released FPCL (unpublished data), a response
that has been reported to involve an integrin-dependent
pathway.33 In contrast to the reported stimulation of FPCL
contraction by virally induced overexpression of human
MMP-1334 or by age-related ﬁbroblast overexpression of rat
MMP-2 and MMP-9,35 elevated Mmp10 and Mmp13 gene
expression in the KO ﬁbroblast appeared to have no acceler-
ating effect on FPCL reorganization. There may be a defect in
the synthesis, secretion, activation, or activity of these metal-
loproteinases. It is also possible that MMP-10 and MMP-13
activities are concentrated at the cell surface of KO cells,
thereby preventing interactions of KO cells with their peri-
cellular environment or, alternatively, that binding and
response to ECM is affected by deletion of Ankrd1. Further
studies will be needed to localize and to determine the relative
activities ofMMPs and ECM receptors in vivo and in vitro and
to establish the effects of MMP inhibition.
Necrotic Phenotype in the Absence of Ankrd1
The more dramatic phenotype of the KO mouse was the
extent of necrosis in a pedicled ﬂap. The null animals
showed extensive ﬂap necrosis, and the haploinsufﬁcient
animals conﬁrmed a gene dosage effect. This outcome,
particularly in light of rescue by overexpression of adeno-
viral Ankrd1, was consistent with our earlier report on the
capacity of adenoviral delivery of Ankrd1 to enhance neo-
vascularization in several wound models.1 The suscepti-
bility to vascular insufﬁciency may also be related to the
initial identiﬁcation of ANKRD1 as a protein prominently
expressed in cytokine-stimulated vascular endothelial
cells36 and subsequently localized in vascular smooth
muscle cells.37e39 ANKRD1 has been reported to augment
Tp53-stimulated MyoD promoter activity in skeletal mus-
cle cells, whereas Tp53 can augment Ankrd1 transcription,
suggesting a potential positive feedback loop.21 There is
also the potential that overexpression of MMP-10 and
MMP-13 is occurring in the KO vasculature as well,
exerting an effect on initiation or maturation of stable
vasculature. Many forms of stress and injury induce
ANKRD1 expression,5,16,31,40 and MARP proteins may
wield more generally protective roles in cells under
ischemic stress.3,41,42 Selective deletion of Ankrd1 in
vascular cells will certainly help to address the vascular
aspects of the Ankrd1-null phenotype.
The signiﬁcant effect of Ankrd1 deletion on wound
contraction, together with the dramatic inability of
Ankrd1-null ﬁbroblasts to contract an ECM equivalent,
suggests that ANKRD1 may function in a pathway thatThe American Journal of Pathology - ajp.amjpathol.orgnormally transduces cell-matrix interaction into contractile
activity, at least in the low-tension environment of the
FPCL and, by analogy, granulation tissue. In addition to
ANKRD1 association with other components in the
classic, sarcomere contractile apparatus, ANKRD1 also
binds to desmin,43 and desmin knockdown has suggested
that this ﬁlamentous protein may regulate Ankrd1
expression through an Akt/NF-kB pathway.23 Equally
intriguing are the reports that both Ankrd1 and CCN2,
which are strongly induced during injury and repair, are
downstream transcriptional targets of a mechanical strain
response that is mediated by the YAP/TAZ pathway.44e47
If cell contraction in the FPCL depends on Ankrd1
expression, then it may be a rate-limiting mediator of
mechanotransduction during wound repair, in which there
is disruption of the normal mechanical environment.Acknowledgments
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